Related Articles
miR‑185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2
miR‑218 inhibits glucose metabolism in non‑small cell lung cancer via the NF‑κB signaling pathway
lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α
Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth
miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors